Bronchiolocentric Interstitial Pneumonia Concerns

The BIP Idea: Bronchiolocentric interstitial pneumonia defines ILD and fibrotic changes centered “along the airways,” Dr. Amita Sharma updated in her ARRS Quick Bytes video.

  • Neither UIP, Nor NSIP: Unlike usual interstitial pneumonia or nonspecific interstitial pneumonia—which feature peripheral opacities—BIP presents with airway-focused abnormalities.
    • Central fibrosis, ground-glass opacities, centrilobular nodules, and lobular lucency are all key findings.

Beyond HP, Too: Whereas Dr. Sharma does consider fibrotic hypersensitivity pneumonitis “the poster child” for bronchiolocentric involvement, BIP’s framework formalizes that non-HP causes can produce identical imaging features.

  • Broader Etiologies: BIP encompasses changes driven by connective tissue diseases, drug-induced toxicity, and aspiration.
  • IRL Dilemma: Patients presenting with a classic HP-like imaging pattern may actually have an underlying autoimmune condition (e.g., rheumatoid arthritis in Sharma’s case here).

Originally used primarily as a histologic descriptor, recent consensus statements bridge histopathologic findings of HP/BIP with high-res CT correlation—a trajectory similar to the introduction of idiopathic NSIP.

  • Classification divides cases attributable to a known trigger or systemic disease (secondary BIP) and no identifiable cause (idiopathic BIP).
    • Refinements clarify distinctions between secondary and idiopathic fibrotic vs. non-fibrotic alveolar and interstitial diseases.

Clinical Concern: Diagnosing a patient with ‘idiopathic BIP’ risks deterrence from searching for an environmental antigen, which remains the most crucial step in managing HP.

RadFYI: Work backward to firmly establish and validate the radiological-pathological correlation for bronchiolocentric interstitial pneumonia.

Comments

Leave a Reply

Your email address will not be published. Required fields are marked *